Approval · Notice of Compliance 25095 · 2021
BUSCOPAN: Notice of Compliance 25095
Issued January 27, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25095
- Date
- January 27, 2021
- Company
- Sanofi Consumer Health IncLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in product ownership
Products in this notice
Medicinal ingredients
- HYOSCINE BUTYLBROMIDE 10 MG per TAB
- HYOSCINE BUTYLBROMIDE 20 MG per ML